Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01561326 · ClinicalTrials.gov registry record · NA
Facilitating Follow-Up Adherence for Abnormal Pap Smears
A NA study, sponsored by Fox Chase Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 211
- Enrollment target
NCT01561326 is a NA study that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 211 participants.
The verdict
NCT01561326, a NA study, has completed, sponsored by Fox Chase Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 211 participants
- Enrollment target
Study Summary
Objective: Previous studies have suggested that psycho-educational interventions delivered by telephone improve adherence to initial colposcopy after an abnormal Pap smear. To further explore strategies for enhanced follow-up to medical care recommendations, we studied the impact of a theory-guided cognitive-affective barriers counseling intervention, delivered at 2-4 weeks before the colposcopy appointment, for inner city women. The comprehensive telephone barriers intervention was compared to an enhanced comparison group and a group that received tailored print materials. Methods: Participants (N = 211) were recruited through a colposcopy clinic and randomly assigned to: 1) telephone assessment of barriers to follow up adherence recommendations combined with tailored telephone barriers counseling; 2) telephone assessment combined with tailored barriers print brochure; or 3) telephone assessment with no barriers counseling. Participants were assessed at baseline, 1-week, 9 and 15 months post-colposcopy.
Interventions
- BEHAVIORAL standard care
- BEHAVIORAL Cognitive-affective barriers counseling
- BEHAVIORAL Cognitive-affective barriers counseling via brochure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2005-05 |
| Est. Completion | 2011-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01561326
The ClinicalTrials.gov registry entry for NCT01561326 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 211 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fox Chase Cancer Center, which has 183 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which standard care is the first listed.
NCT01561326 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01561326 about?
NCT01561326 is a clinical study titled "Facilitating Follow-Up Adherence for Abnormal Pap Smears". Objective: Previous studies have suggested that psycho-educational interventions delivered by telephone improve adherence to initial colposcopy after an abnormal Pap smear. To further explore strategies for enhanced follow-up to medical care recommendations, we studied the impact of a theory-guided ...
What is the current status of trial NCT01561326?
This trial is currently completed. It is a NA study. The enrollment target is 211 participants. The study started on 2005-05. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01561326?
The interventions under investigation include: standard care (BEHAVIORAL), Cognitive-affective barriers counseling (BEHAVIORAL), Cognitive-affective barriers counseling via brochure (BEHAVIORAL).
Who is sponsoring clinical trial NCT01561326?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.